[S-40] シンポジウム40 Dyskinesia in Parkinson's Disease: Filling the Bedside-to-Bench Gap

[S-40-1] ジスキネジアの臨床的特徴、リスク要因、患者への負担：Update

^○武田 篤^1,2 (1.国立病院機構仙台西多賀病院 脳神経内科, 2.東北大学連携大学院高齢者認知運動機能障害学講座)

Atsushi Takeda
Director, National Hospital Organization, Sendai-Nishitaga Hospital

Dr. Takeda MD, PhD, is a Director of National Hospital Organization, Sendai-Nishitaga Hospital and a visiting Professor in the department of Cognitive & Motor Aging in Tohoku University, Graduate School of Medicine. He received his MD (1985) and PhD degrees (1992) from Tohoku University. His special interests are focused on pathophysiological mechanisms of cognitive and movement impairments in the synucleinopathies. He organized a multicenter- randomized double-blinded clinical trial of donepezil on Parkinson disease with severe hyposmia (Granted by AMED). He is currently also a vice chairman of the Ad Hoc committee for the Japanese clinical practice guidelines of Parkinson disease.